Strength Training Study for Survivors of Breast and Gynecologic Cancer

NCT ID: NCT01709175

Last Updated: 2015-06-08

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 20 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2012-11-30
• Study Completion Date: 2015-01-31

Brief Summary

The purpose of this study is to compare once-a-week vs. twice-a-week strength training in survivors of breast and gynecologic cancer to determine which is the optimal exercise prescription.

Detailed Description

As a result of cancer and its treatment, survivors of breast and gynecologic cancer are reported to have deficits in both physical and psycho-social health. In cancer survivors exercise has been shown to improve fitness, increase bone density and lean body mass, enhance self-esteem, and reduce fatigue. These changes have a positive effect on the survivor's physical functioning and quality of life. However, there are few studies which have examined the effects of strength training or studies aimed at determining optimal exercise prescription in this population. Therefore, the purpose of this study is to compare two strength training prescriptions (once-a-week vs. twice-a-week strength training) to determine which prescription (if any) results in greater benefit for survivors. It is hoped that the results of this study will lead to a better understanding of how strength training improves the health of survivors and will help inform future exercise guidelines for this population.

Conditions

Breast Cancer; Gynecologic Cancer; Ovarian Cancer; Uterine Cancer; Cervical Cancer

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SCREENING
• Blinding Strategy: NONE

Study Groups

Once-a-week Strength Training

After completing the introduction to strength training (two sessions in the first week), participants randomized to the once-a-week group will receive 12 additional weeks of progressive strength training. Participants will meet ONCE-A-WEEK to strength train in a supervised exercise group. The program includes nine exercises.

Group Type: EXPERIMENTAL

Strength Training

Intervention Type: BEHAVIORAL

This is a 13 week strength training program. Sessions will be supervised by a Certified Exercise Physiologist in a group setting.

Twice-a-week Strength Training

After completing the introduction to strength training (two sessions in the first week), participants randomized to the twice-a-week group will receive 12 additional weeks of progressive strength training. Participants will meet TWICE-A-WEEK to strength train in a supervised exercise group. The program includes nine exercises.

Group Type: EXPERIMENTAL

Strength Training

Intervention Type: BEHAVIORAL

This is a 13 week strength training program. Sessions will be supervised by a Certified Exercise Physiologist in a group setting.

Interventions

Strength Training

This is a 13 week strength training program. Sessions will be supervised by a Certified Exercise Physiologist in a group setting.

Intervention Type: BEHAVIORAL

Other Intervention Names

Resistance Exercise; Weight Training; Body Building; Exercise; Physical Activity; Restive Exercise

Eligibility Criteria

Inclusion Criteria

• Female Survivor of Breast or Gynecologic Cancer
• Completed Primary Treatment (hormone treatments are ok)
• 18 years of age or older
• Physician's Permission to Participate

Exclusion Criteria

• High Risk Individuals (determined by questionnaire)
• Secondary Health Problems that could increase the risk of participating (Includes but not limited to: Uncontrolled angina/hypertension, heart failure, osteoporosis, brain metastases, history of seizures).
• Report participating in a strength training program in the past six (6) months
• Have had a change in medication in the past 30 days

• Minimum Eligible Age: 18 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Dalhousie University

OTHER

Sponsor Role: collaborator

Nova Scotia Health Authority

OTHER

Sponsor Role: lead

Responsible Party

Scott Grandy

Principle Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Scott Grandy, Ph D

Role: PRINCIPAL_INVESTIGATOR

CDHA

Locations

Exercise Lab: Queen Elizabeth II Dickson Centre

Halifax, Nova Scotia, Canada

Countries

Canada

Other Identifiers

JB-007

Identifier Type: -

Identifier Source: org_study_id